Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Chiglitazar Intervention in Obese/Overweight Prediabetes
ChiCTR2600125944Phase 4Not yet recruiting
- Sponsor
- Pengzhou People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in prediabetes comparing Chiglitazar sodium + lifestyle intervention with Placebo + lifestyle intervention (2 arms). Primary endpoints: Fasting plasma glucose, 2-hour postprandial plasma glucose and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
chiglitazar
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR2600125944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125944.